F3 Platform Biologics, Inc. (JDRR)

F3 Platform Biologics was planning to go public, but the IPO was withdrawn on Jun 20, 2024.

Stock Price: Pending

IPO price not available yet

F3 Platform Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2022	2021
Debt / Equity Ratio	-0.84	-0.87	-0.87
Debt / EBITDA Ratio	-7.68	-9.54	-2.78
Debt / FCF Ratio	-13.39	-15.18	-55.72
Quick Ratio	0.09	0.12	0.04
Interest Coverage	-2.47	-2.06	-6.84
Return on Equity (ROE)	15.36%	13.52%	35.99%
Return on Assets (ROA)	-	-262.78%	-1555.92%
Return on Capital (ROIC)	68.30%	69.47%	249.47%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).